This page describes technologies and techniques that exist in international healthcare, and where they are established. It is information only. It is not an offer to treat any condition, not a recommendation, and not a substitute for advice from a clinician who knows your case.
Why this page is written carefully
Advanced treatments attract marketing that runs well ahead of the evidence, and cancer treatment in particular is heavily regulated: in the UK it is an offence to publish an advertisement offering to treat cancer or offering advice on its treatment. So this page explains what these technologies are and where capacity exists, and stops there. Whether any of them is appropriate for you is a question for your own specialist.
Surgical technology
- Robotic surgery. Robot-assisted platforms give improved visualisation and instrument articulation in confined spaces. Established for prostate, gynaecological, colorectal and increasingly thoracic surgery. Evidence of benefit is strongest where access is difficult; for many operations the outcome difference against skilled laparoscopy is small.
- Minimally invasive spine surgery. Smaller incisions, less muscle disruption and shorter hospital stay. Technically demanding — surgeon experience matters more than the label.
- Robotic bronchoscopy. Navigational platforms reaching peripheral lung nodules that conventional bronchoscopy cannot, allowing biopsy without surgery.
- MRI-guided laser ablation (LITT). Real-time imaging guides a laser fibre to treat lesions through a small opening rather than open surgery. Used in selected epilepsy and neuro-oncology cases.
Cardiac technology
- TAVI / TAVR. Aortic valve replacement via catheter rather than open-heart surgery. Initially for patients unsuitable for surgery, now used across a widening risk range.
- Cardiac neuroablation. A catheter technique modifying autonomic input to the heart, used in selected rhythm disorders.
- Remote cardiac monitoring. Implanted or wearable devices transmitting rhythm data continuously, allowing follow-up without in-person visits — useful if you are treated abroad and monitored at home.
Oncology technology
The following exist internationally and are mentioned here because patients ask what they are. Availability, suitability and evidence differ enormously by cancer type and stage. None of this is a recommendation, and any of it should be discussed with your own oncology team.
- Proton beam therapy. Radiotherapy using protons rather than photons, depositing dose more precisely and sparing surrounding tissue. Its clearest established role is in paediatric tumours and tumours adjacent to critical structures. Compact systems have widened availability, but it is not superior to conventional radiotherapy for most cancers.
- Precision oncology and genomic profiling. Sequencing tumour tissue to identify mutations that may be targetable. Informative in some cancers, uninformative in others.
- Immunotherapy. Treatments harnessing the immune system, now standard in several cancers. These are prescription-only medicines and cannot lawfully be advertised to the public in the UK or EU.
- CAR-T and cellular therapy. Engineering a patient’s own immune cells against their cancer. Established in specific blood cancers, delivered only at accredited centres, and highly regulated.
A note on “breakthrough” marketing. If a clinic markets an advanced therapy directly to patients, promises outcomes, or offers a proprietary protocol unavailable anywhere else, treat that as a warning rather than a selling point. Genuine centres of excellence take referrals and discuss cases in multidisciplinary boards; they do not sell treatment from a landing page.
Fertility technology
- Time-lapse embryo monitoring. Continuous imaging inside the incubator to inform embryo selection without disturbing culture conditions.
- Preimplantation genetic testing. Screening embryos for chromosomal abnormalities before transfer. Benefit varies with maternal age and is debated in younger patients.
- Vitrification. Ultra-rapid freezing giving markedly better survival rates for eggs and embryos than older slow-freeze methods.
Remote and follow-up care
Telemedicine has changed medical travel more quietly than any of the technologies above. Remote second opinions mean many patients never need to travel at all, and remote follow-up closes the aftercare gap that has always been the weakest part of treatment abroad. When comparing clinics, ask what remote follow-up is included and for how long — it is often more consequential than which robot they own.
Where these are established
Broadly: Germany and Singapore for proton therapy, precision oncology and complex robotic surgery; the UAE for advanced cardiac and robotic programmes; India for high-volume robotic and cardiac work at lower cost; Turkey for robotic surgery and advanced fertility laboratories.
If you want to understand whether any of this is relevant to your situation, the sensible first step is usually a specialist second opinion on your existing diagnosis — not a search for a technology.